Houston/ Crime & Emergencies

Houston Man Gets 22 Years for Selling Meth, Guns to Undercover Agent

AI Assisted Icon
Published on October 26, 2026
Houston Man Gets 22 Years for Selling Meth, Guns to Undercover AgentSource: Ye Jinghan / Unsplash

A 39-year-old Houston man has been sentenced to 264 months, or 22 years, in federal prison after a jury found he sold firearms and kilogram quantities of crystal methamphetamine to an undercover agent. Jorge Morales was also ordered to serve five years of supervised release once his prison term ends.

Federal prosecutors said Morales was sentenced following his conviction on multiple drug and firearm charges, according to Click2Houston. A federal jury convicted Morales on January 16 after a four-day trial.

Investigators said Morales did not limit his dealing to in-person meetings. He used his Instagram account to solicit and negotiate sales of firearms and narcotics, according to the same report. That detail became part of the evidence prosecutors built against him over the course of the trial.

Morales Awaits Transfer to Federal Facility

Morales remains in custody pending transfer to a Federal Bureau of Prisons facility, which will be determined in the near future.

Morales' combined sentence reflects how federal law treats firearm offenses tied to drug trafficking. Under guidance from the United States Sentencing Commission, the guideline sentence for an offense under 18 U.S.C. § 924(c) is the minimum term required by statute, and punishments under that statute run consecutively to any other prison time imposed — meaning a firearm conviction tacks additional, mandatory years onto a drug sentence rather than running alongside it.

Case Drew on Multiple Law Enforcement Agencies

The Texas Department of Public Safety and the Bureau of Alcohol, Tobacco, Firearms and Explosives investigated the case.

Morales' case is not an isolated one in federal methamphetamine enforcement. The U.S. Sentencing Commission reported that 7,573 individuals were sentenced for methamphetamine offenses under its drug guidelines in fiscal year 2025, underscoring how common cases like this one have become across the federal court system.